Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Charlotte Manisty, Ashley Otter, Thomas A. Treibel, Áine McKnight, Daniel M. Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J. Boyton, Amanda Semper, James Moon
Topics & Concepts
VaccinationImmunogenicityMedicineScopusCoronavirus disease 2019 (COVID-19)Christian ministrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPopulationAntibodyMEDLINEImmunologyEnvironmental healthInternal medicinePolitical scienceLawInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Immunology Research